Colon cancer: molecular markers

被引:2
作者
Arnold, CN [1 ]
Blum, HE [1 ]
机构
[1] Univ Freiburg, Innere Med Abt 2, D-79106 Freiburg, Germany
关键词
D O I
10.1055/s-2005-865102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:880 / 882
页数:3
相关论文
共 15 条
[1]   Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel [J].
Ahlquist, DA ;
Skoletsky, JE ;
Boynton, KA ;
Harrington, JJ ;
Mahoney, DW ;
Pierceall, WE ;
Thibodeau, SN ;
Shuber, AP .
GASTROENTEROLOGY, 2000, 119 (05) :1219-1227
[2]   Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines [J].
Arnold, CN ;
Goel, A ;
Boland, CR .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (01) :66-73
[3]   Colon cancer: molecular pathogenesis and clinical relevance [J].
Arnold, CN ;
Blum, HE .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (13) :809-811
[4]   DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study [J].
Barratt, PL ;
Seymour, MT ;
Stenning, SP ;
Georgiades, I ;
Walker, C ;
Birbeck, K ;
Quirke, P .
LANCET, 2002, 360 (9343) :1381-1391
[5]   Fecal Multiple Molecular Tests to Detect Colorectal Cancer in Stool [J].
Calistri, Daniele ;
Rengucci, Claudia ;
Bocchini, Renato ;
Saragoni, Luca ;
Zoli, Wainer ;
Amadori, Dino .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2003, 1 (05) :377-383
[6]   Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer [J].
Carethers, JM ;
Smith, EJ ;
Behling, CA ;
Nguyen, L ;
Tajima, A ;
Doctolero, RT ;
Cabrera, BL ;
Goel, M ;
Arnold, CA ;
Miyai, K ;
Boland, CR .
GASTROENTEROLOGY, 2004, 126 (02) :394-401
[7]   Detecting colorectal cancer in stool with the use of multiple genetic targets [J].
Dong, SM ;
Traverso, G ;
Johnson, C ;
Geng, L ;
Favis, R ;
Boynton, K ;
Hibi, K ;
Goodman, SN ;
D'Allessio, M ;
Paty, P ;
Hamilton, SR ;
Sidransky, D ;
Barany, F ;
Levin, B ;
Shuber, A ;
Kinzler, KW ;
Vogelstein, B ;
Jen, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (11) :858-865
[8]  
Fallik D, 2003, CANCER RES, V63, P5738
[9]   Methylation changes in faecal DNA:: a marker for colorectal cancer screening? [J].
Müller, HM ;
Oberwalder, M ;
Fiegl, H ;
Morandell, M ;
Goebel, G ;
Zitt, M ;
Mühlthaler, M ;
Öfner, D ;
Margreiter, R ;
Widschwendter, M .
LANCET, 2004, 363 (9417) :1283-1285
[10]   Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer [J].
Ribic, CM ;
Sargent, DJ ;
Moore, MJ ;
Thibodeau, SN ;
French, AJ ;
Goldberg, RM ;
Hamilton, SR ;
Laurent-Puig, P ;
Gryfe, R ;
Shepherd, LE ;
Tu, D ;
Redston, M ;
Gallinger, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (03) :247-257